Methyl Isobutyl Ketone

Methyl Isobutyl Ketone

SCHEMBL20475873

CC(=O)CC(C)C.C[S+](C)[O-].C[S+](C)[O-]

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MAP2K1MAP2K2

The experimentally established mechanism targets of Methyl Isobutyl Ketone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.74
TDP1 Q9NUW8 2/20 0.74
CA2 P00918 1/20 0.46
CA1 P00915 2/20 0.33
CYP2C19 P33261 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31
MMP9 P14780 1/20 0.31
MMP13 P45452 1/20 0.31
KISS1R Q969F8 2/20 0.31
TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Isobutyl Ketone SCHEMBL3219315 1.00 ALDH1A1 (0.74) ALDH1A1TDP1CA2CA1CYP2C19
Methyl Isobutyl Ketone SCHEMBL1580340 0.86
Methyl Isobutyl Ketone SCHEMBL1128055 0.86 ALDH1A1 (1.00) ALDH1A1TDP1CA2CYP2C19SMN1; SMN2
Methyl Isobutyl Ketone SCHEMBL15458 0.86
Methyl Isobutyl Ketone SCHEMBL9056069 0.83 ALDH1A1 (0.82) ALDH1A1TDP1CA2CYP2C19SMN1; SMN2
Methyl Isobutyl Ketone SCHEMBL809423 0.83
Methyl Isobutyl Ketone SCHEMBL842835 0.83
Methyl Isobutyl Ketone SCHEMBL2188913 0.83
Methyl Isobutyl Ketone SCHEMBL358566 0.83
Methyl Isobutyl Ketone SCHEMBL7073455 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020215155-A1 CRYSTAL FORM S4 OF THE PLK4 INHIBITOR (LR,2S)-(E)-2-(3-(4-((CIS-2,6-DIMETHYLMORPHOLINO)METHYL)STYRYL)- 1 H-IMIDAZOL-6- YL)-5'-METHOXYSPIRO[CYCLOPROPANE-L,3'-INDOLIN]-2'-ONE FUMARATE UNIVERSITY HEALTH NETWORK (CA) 2020-10-29 WO disclosed
WO-2018151815-A1 PROCESSES FOR PREPARING AG-10, ITS INTERMEDIATES, AND SALTS THEREOF Eidos Therapeutics, Inc. (US) 2018-08-23 WO disclosed